Investigations have looked at the extent to which genetic similarity between family members is associated with the likelihood of developing SZ.
There have been some studies investigating genetic similarity and the risk of SZ.
Gottesman carried out a large-scale family study, which suggests that the more genetic similarity, the higher the chance for developing SZ. For example, identical twins share 100% of their genes and they have 48% chance of developing SZ. Whereas non-identification twins who share 50% of their genes only have 17% risk of developing SZ.
Candidate genes
Individual genes are associated with the risk of inheritance.
Schizophrenia is polygenic.
Schizophrenia is aetiologically heterogenous (different combinations of factors can lead to the condition)
Research support: Ripke et al
Research support for candidate genes
Ripke et al, genetic make-up of 37,000 patients was compared to that of 113,000 controls.
108 separate genetic variations were associated with increased risk of schizophrenia.
Genes associated with increased risk included those coding for the functioning of a number of neurotransmitters including dopamine.
Role of mutation
Schizophrenia can occur without any family history of the disorder.
One explanation of this is mutation in parental DNA.
Mutation of sperm cells can be caused by radiation, poison or viral infection.
Research support for role of mutation
Positive correlation between paternal age (associated with increased risk of sperm mutation) and the risk of developing SZ.
Increasing from 0.7% with fathers under 25 to over 2% in fathers over 50.
Brown et al
Research support for genetic vulnerability
Gottesman family study clearly shows how genetic similarity and shared risk of SZ are closely related.
Tienari et al, adoption studies show children of people with SZ are still at heightened risk of SZ if adopted into families without a history of SZ.
There is evidence which in favour of the role genetic factors play which makes people more vulnerable to developing schizophrenia than other.
However not entirely genetic as environmental factors are associated with SZ.
Environmental factors not included in the genetic explanation
Morkved et al found that 67% of people with SZ and related psychotic disorders reported at least 1 childhood trauma.
This shows that psychological risk factors like childhood trauma leaves people more vulnerable to developing SZ.
Therefore this suggests that genetic factors alone cannot provide a completeexplanation of SZ.
Real life application of geneticexplanation
For example, based on Gottesman’s study there will be a 2% probability of developing SZ if a child has an uncle or aunt with SZ, and 6% probability if they have a half-sibling with it.
This shows if one or more potential parents have a relative with SZ, they risk having a child who would go on to develop the condition.
Genetic counselling involves informing potential parents of these probabilities so they can make informed decisions of whether to have children as they may have a poor quality of life if they develop SZ.
Neural correlates
Refers to when measurement of structures or functions of the brain correlate with SZ
The dopamine hypothesis
The brains chemical messengers appear to work differently in the brain of a patient with SZ.
In particular dopamine is widely believed to be involved.
Dopamine is important in the functioning of several brain systems that may be implicated in the symptoms of SZ
Original dopamine hypothesis: Hyperdopaminergia
Hyper= high
Excess amounts of dopamine receptions in the BROCA’S area may be associated with speech poverty or auditory hallucinations.
Schizophrenics are thought to have high numbers of dopamine receptions on receiving neurones, resulting in more dopamine binding therefore more dopamine firing.
Updated dopamine hypothesis: Hypodopaminergia
Hypo= Low
Davis et al, found low levels of dopamine in the brain’s cortex.
E.g low levels of dopamine in the prefrontal cortex could explain cognitive problems e.g negative symptoms of SZ
How can we determine which dopamine hypothesis to use?
It may be that both hyperdopaminergia and hypodopaminergia are correct explanations.
Both high and low levels of dopamine in different brain regions are involved in SZ.
Evidence for dopamine
Amphetamine increases levels of dopamine and can make SZ worse by producing schizophrenia-like symptoms in non-sufferers.
Antipsychotic drugs reduce levels of dopamine and can reduce the intensity of SZ symptoms.
Suggests that dopamine is involved in the symptoms of SZ.
Contradictory evidence for glutamate
McCutcheon et al, Post-mortem and live scanning studies have consistently found raised levels of glutamate in several brain regions of people with SZ.
Other candidate genes for SZ are believed to be involved with glutamate production.
Therefore this means other neurotransmitters are involved in SZ other than dopamine.
Use of correlational research in neural correlates. Why is this bad?
It is not clear whether abnormal dopamine level cause SZ or whether it is a result of SZ.
Shows that the causes of SZ may not be as a result of dopamine levels alone. The abnormal brain activity could be caused by another factor such as trauma.
It is difficult to use correlational evidence to imply causation because there may be other intervening factors such as the environment that causes this effect.